marginally significantp = 0.081
We find a significantly lower incidence rate of Anorexia in TheraBionic patients (1 patient; 2%) relative to the SHARP study (incidence rate of 14%) ( p = 0.041), and a marginally significant difference compared to the Asia-Pacific study (incidence rate of 13%) ( p = 0.081).